logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
S

Shirish M. Gadgeel

division of hematology and oncology, henry ford hospital , detroit, michigan ,

76H指数
845论文数
4.2W被引数
收录论文 177
发表时间
logo
Clinical overview of trophoblast surface antigen 2 Antibody-Drug conjugates in Non–Small cell lung cancer滋养层表面抗原2抗体偶联物在非小细胞肺癌中的临床概述
errCancer Treatment Reviews
IF10.5
err2025-11-16
err0
PREAI
errSandip Pravin Patel; Shirish Gadgeel; Mari Mino-Kenudson; Jarushka Naidoo; Nan Sethakorn
err分享
err收藏
\zaAlectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: Final overall survival analysis of the Phase III ALEX study阿来替尼对比克唑替尼用于初治ALK阳性晚期非小细胞肺癌：III期ALEX研究最终总生存期分析
errAnnals of Oncology
IF65.4
err2025-10-17
err0
errOAAI
errS. Peters; R. Camidge; R. Dziadziuszko; S. Gadgeel; A.T. Shaw; D-W. Kim; M. Pérol; D.R. Rosell; P. Cheema; D.Wan-Teck Lim; J.J. Lin; N. Pavlakis; J.S. Ahn; L. Zhang; V. Henschel; A.A. Higgerson; V. McNally; I. Rooney; A. Scalori; V. Smoljanovic; T. Mok
err分享
err收藏
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC)帕博利珠单抗联合铂类为基础的化疗在EGFR和ALK基因突变非小细胞肺癌（NSCLC）复发患者中的应用
errClinical Lung Cancer
IF3.3
err2025-10-03
err0
PREAI
errShirish M. Gadgeel; Misako Nagasaka; Karen Dziubek; Thomas Braun; Khaled Hassan; Haiying Cheng; Balazs Halmos; Antoinette Wozniak; James Stevenson; Pradnya Patil; Nathan Pennell; Mary Jo Fidler; Angel Qin; Zeqi Niu; Sunitha Nagrath; Gregory P. Kalemkerian
err分享
err收藏
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC携带EGFR突变型晚期非小细胞肺癌患者使用amivantamab-lazertinib的总体生存率
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-09-01
err9
PREAI
errYang, James Chih-Hsin; Lu, Shun; Hayashi, Hidetoshi; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Kim, Yu Jung; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Passaro, Antonio; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong Ignatius; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan Carlos; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet Ali Nahit; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Kim, Sang-We; Gadgeel, Shirish M.; Owen, Scott; Xie, John; Sun, Tao; Mehta, Jaydeep; Venkatasubramanian, Raja; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Roshak, Amy; Man, Julie; Knoblauch, Roland E.; Bauml, Joshua M.; Baig, Mahadi; Shah, Sujay; Sethi, Seema; Cho, Byoung Chul
err分享
err收藏
Is Shorter Better in Oncology Patients, Too? A Retrospective Cohort Study of Short- Versus Long-Course Antibiotic Therapy for Uncomplicated Infections in Solid Tumor Patients Receiving Care in Ambulatory Oncology Clinics在实体肿瘤患者中，较短疗程的抗生素疗法是否也更好？——一项关于在门诊肿瘤诊所接受治疗的实体肿瘤患者中，简化感染患者抗生素疗程（短程与长程）的回顾性队列研究
errOpen Forum Infectious Diseases
IF3.8
err2025-08-21
err0
errOAAI
errChristen J Arena; Beisan El-Tatari; Kristen Lovric; Sage B Greenlee; Rachel M Kenney; Shirish M Gadgeel; Katelyn Patterson; Anita B Shallal; George J Alangaden; Susan L Davis; Michael P Veve
err分享
err收藏
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutationGarsorasib，一种KRAS G12C抑制剂，有或没有西妥昔单抗，一种EGFR抗体，在患有KRAS G12C突变的晚期实体瘤的II期临床试验的结直肠癌队列中
errSignal Transduction and Targeted Therapy
IF52.7
err2025-06-17
err0
errOAAI
errDan-Yun Ruan; Hao-Xiang Wu; Ye Xu; Pamela N. Munster; Yanhong Deng; Gary Richardson; Dong Yan; Myung-Ah Lee; Keun-Wook Lee; Hongming Pan; Steven Hager; Xingya Li; Shaozhong Wei; Xinfang Hou; Craig Underhill; Michael Millward; Ina Nordman; Jingdong Zhang; Jianzhen Shan; Guohong Han; Jaspreet Grewal; Shirish M. Gadgeel; Rachel E. Sanborn; Seok Jae Huh; Xiaohua Hu; Yihong Zhang; Ziyong Xiang; Laisheng Luo; Xiaoxi Xie; Zhe Shi; Yaolin Wang; Ling Zhang; Feng Wang; Rui-Hua Xu
err分享
err收藏
A Response to the Letter to the Editor: “Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World?”对编辑信函的回应：“我们能否在真实世界中优化ALK阳性晚期NSCLC患者的一线治疗标准？”
errJournal of Thoracic Oncology
IF20.8
err2025-06-06
err0
PREAI
errVincent K. Lam; Shirish M. Gadgeel
err分享
err收藏
Real-world characteristics and survival outcomes of patients with metastatic ALK fusion-positive solid tumors treated with standard-of-care therapies真实世界中接受标准护理治疗的患者，其ALK融合阳性转移性实体瘤的临床特征和生存结局
errONCOLOGIST
IF4.2
err2025-05-08
err0
errOAAI
errGadgeel, Shirish M.; Fajardo, Otto; Barlesi, Fabrice; Kim, Jeong Eun; Kurzrock, Razelle; Thomas, David M.; Jagtiani, Ritika; Noe, Johannes; Schwemmers, Sven; Nikolaidis, Christos
err分享
err收藏
Plain language summary of first-line amivantamab-lazertinib in previously untreated high-risk EGFR-altered non-small-cell lung cancer in MARIPOSA易瑞沙-拉泽替尼在既往未治疗的高危EGFR突变非小细胞肺癌MARIPOSA研究中的简明语言总结
errFUTURE ONCOLOGY
IF2.6
err2025-04-24
err0
errOAAI
errFelip, Enriqueta; Cho, Byoung Chul; Lu, Shun; Sendur, Mehmet Ali Nahit; Gadgeel, Shirish M.; Sethi, Seema; Bauml, Joshua M.; Hayashi, Hidetoshi
err分享
err收藏
Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy第1周期中，与住院48小时监测相比，门诊6-8小时监测下塔拉他玛单抗的安全性：DeLLphi-300期1期子研究
errESMO OPEN
IF8.3
err2025-04-01
err0
errOAAI
errChiang, A. C.; Garcia, M. E. Olmedo; Carlisle, J. W.; Dowlati, A.; Reguart, N.; Felip, E.; Jost, P. J.; Steeghs, N.; Stec, R.; Gadgeel, S. M.; Loong, H. H.; Jiang, W.; Hamidi, A.; Parkes, A.; Paz-Ares, L.
err分享
err收藏
Lung Carcinoid Tumors With Potentially Actionable Genomic Alterations and Responses to Targeted Therapies具有潜在可操作基因组改变的肺类癌肿瘤及其对靶向治疗反应
errClinical Lung Cancer
IF3.3
err2025-03-25
err0
PREAI
errSarah Waliany; Yin P. Hung; Fawzi Abu Rous; Faustine Luo; Marzia Capelletti; Steven Ressler; Andrew Do; Jennifer Peterson; Caitlin Meservey; Subba R. Digumarthy; Sai-Hong Ignatius Ou; Shirish M. Gadgeel; Jessica J. Lin; Catherine B. Meador
err分享
err收藏
Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers种族多样性及与EGFR突变肺癌相关的生物学意义共突变分析
errClinical Lung Cancer
IF3.3
err2025-02-14
err0
PREAI
errRadhika Gutta; Emily Teslow; Ellen Jaeger; Melissa C. Stoppler; Calvin Chao; Fawzi Abu Rous; Bindu Potguari; Shirish Gadgeel
err分享
err收藏
Even With the CROWN Findings, There Remain Multiple First-Line Treatment Options for Patients With Advanced ALK-Positive NSCLC即使有了CROWN研究结果，对于晚期ALK阳性NSCLC患者，仍然存在多种一线治疗方案。
errJOURNAL OF THORACIC ONCOLOGY
IF20.8
err2025-02-01
err0
PREAI
errLam, Vincent K.; Gadgeel, Shirish M.
err分享
err收藏
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer
errCANCER
IF5.1
err2025-01-28
err0
errOAAI
errSands, Jacob M.; Champiat, Stephane; Hummel, Horst-Dieter; Paulson, Kelly G.; Borghaei, Hossein; Alvarez, Jean Bustamante; Carbone, David P.; Carlisle, Jennifer W.; Choudhury, Noura J.; Clarke, Jeffrey M.; Gadgeel, Shirish M.; Izumi, Hiroki; Navarro, Alejandro; Lau, Sally C. M.; Lammers, Philip E.; Huang, Shuang; Hamidi, Ali; Mukherjee, Sujoy; Owonikoko, Taofeek K.
err分享
err收藏
Response to: Enhancing Clinical Practice: Critical Insights for Medical Workers in Applying Pembrolizumab for Metastatic NSCLC and Pembrolizumab, Chemotherapy and Metastatic Non-Small Cell Lung Cancer回复：增强临床实践：医疗工作者应用Pembrolizumab治疗转移性NSCLC以及Pembrolizumab联合化疗治疗转移性非小细胞肺癌的关键见解
errJOURNAL OF THORACIC ONCOLOGY
IF20.8
err2025-01-01
err0
PREAI
errGadgeel, Shirish M.; Jensen, Erin; Shamoun, Mark; Rajagopalan, Kumar
err分享
err收藏
STREAMLINING THE STUDY INTAKE PROCESS AT THE CANCER CLINICAL AND TRANSLATIONAL RESEARCH OFFICE (CCTRO)
errNEURO-ONCOLOGY
IF13.4
err2024-11-11
err0
PREAI
errFaddah, Raid; Walbert, Tobias; Snyder, James; Gadgeel, Shirish; Philip, Philip; Lange, Lisa
err分享
err收藏
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLCAmivantamab联合Lazertinib治疗先前未经治疗的EGFR突变的晚期NSCLC
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2024-10-24
err25
PREAI
errCho, Byoung C.; Lu, Shun; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Lee, Jong-Seok; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Yang, James C. -H.; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong I.; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan C.; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet A. N.; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Passaro, Antonio; Kim, Sang-We; Gadgeel, Shirish M.; Xie, John; Sun, Tao; Martinez, Melissa; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Millington, Dawn; Leconte, Isabelle; Iwasawa, Ryota; Lorenzini, Patricia; Baig, Mahadi; Shah, Sujay; Bauml, Joshua M.; Shreeve, S. Martin; Sethi, Seema; Knoblauch, Roland E.; Hayashi, Hidetoshi
err分享
err收藏
Diversifying translational research models to address outcomes disparities in lung cancer
errCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
IF3.4
err2024-09-21
err0
PREAI
errPilling, Amanda; Hutchings, Hollis; Cohen, Avi; Gadgeel, Shirish; Okereke, Ikenna
err分享
err收藏
Belvarafenib in patients (pts) with BRAF class II or III alteration-positive tumours: TAPISTRY study贝瓦拉芬尼在BRAF类II或III型突变阳性肿瘤患者(pts)中的研究：TAPISTRY研究
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errDziadziuszko, R.; Damian, S.; Gadgeel, S.; Garralda, E.; Italiano, A.; Kim, J. E.; Krzakowski, M.; Lin, C-C.; Popovtzer, A.; Thomas, D.; Kirschbrown, W.; Patel, S.; Pham, T.; Sbirnac, M.; Wu, F.; Barlesi, F.
err分享
err收藏
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study
errBMC CANCER
IF3.4
err2024-07-25
err1
errOAAI
errBoyer, Michael; Hui, Rina; Urban, Damien; Clingan, Philip; Su, Wu-Chou; Devaux, Celine; Gadgeel, Shirish; Garassino, Marina; Leopold, Lance; Daniel, Jeannie; Munteanu, Mihaela C.; Samkari, Ayman; Luo, Yiwen; Abreu, Delvys Rodriguez
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
P
Pasi A. Jänne
H 指数: 163 · 论文数: 2.3K
M
Mark G. Kris
H 指数: 149 · 论文数: 1.4K
T
Toni K. Choueiri
H 指数: 149 · 论文数: 2.5K
R
Razelle Kurzrock
H 指数: 144 · 论文数: 2.3K
J
James Chih‐Hsin Yang
H 指数: 141 · 论文数: 1.2K
查看更多